Workflow
Ocugen(OCGN)
icon
Search documents
Ocugen(OCGN) - 2022 Q4 - Annual Report
2023-02-27 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________________________________ FORM 10-K ___________________________________________________________ (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36751 _______________________ ...
Ocugen(OCGN) - 2022 Q3 - Earnings Call Transcript
2022-11-08 15:33
Ocugen, Inc. (NASDAQ:OCGN) Q3 2022 Earnings Conference Call November 8, 2022 8:30 AM ET Company Participants Tiffany Hamilton - Head, Corporate Communications Shankar Musunuri - Chairman, Chief Executive Officer & Co-Founder Jessica Crespo - Chief Accounting Officer & Senior Vice President, Finance Conference Call Participants Jennifer Kim - Cantor Fitzgerald Robert LeBoyer - Noble Capital Daniil Gataulin - Chardan Jonathan Aschoff - ROTH Capital Partners Uy Ear - Mizuho Securities Operator Good morning and ...
Ocugen(OCGN) - 2022 Q3 - Quarterly Report
2022-11-07 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________________________________ FORM 10-Q ___________________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-36751 _____________ ...
Ocugen(OCGN) - 2022 Q2 - Earnings Call Transcript
2022-08-05 17:09
Ocugen, Inc. (NASDAQ:OCGN) Q2 2022 Earnings Conference Call August 5, 2022 8:30 AM ET Company Participants Tiffany Hamilton - Head, Corporate Communications Shankar Musunuri - Chairman, Chief Executive Officer and Co-Founder Jessica Crespo - Chief Accounting Officer and Senior Vice President, Finance Conference Call Participants Jennifer Kim - Cantor Jonathan Aschoff - ROTH Capital Partners Daniil Gataulin - Chardan Robert LeBoyer - Noble Capital Markets Swayampakula Ramakanth - H.C. Wainwright Operator Goo ...
Ocugen(OCGN) - 2022 Q2 - Quarterly Report
2022-08-04 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________________________________ FORM 10-Q ___________________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-36751 __________________ ...
Ocugen(OCGN) - 2022 Q1 - Earnings Call Transcript
2022-05-07 00:56
Ocugen, Inc. (NASDAQ:OCGN) Q1 2022 Earnings Conference Call May 6, 2022 8:30 AM ET Company Participants Ken Inchausti - Head, Investor Relations & Communications Shankar Musunuri - Chairman, Chief Executive Officer & Co-Founder Jessica Crespo - Chief Accounting Officer & Senior Vice President, Finance Conference Call Participants Zegbeh Jallah - ROTH Capital Partners Swayampakula Ramakanth - H.C. Wainwright Operator Good morning, and welcome to the Ocugen Conference Call. At this time, all participants ar ...
Ocugen(OCGN) - 2022 Q1 - Quarterly Report
2022-05-05 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________________________________ FORM 10-Q ___________________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36751 __________________ ...
Ocugen (OCGN) Investor Presentation - Slideshow
2022-04-19 17:50
ocugen. Courageous Innovation April 2022 NASDAQ: OCGN Forward Looking Statement This presentation contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995, which are subject to risks and uncertainties. We may, in some cases, use terms such as "predicts," "believes," "potential," "proposed," "continue," "estimates," "anticipates," "expects," "plans," "intends," "may," "could," "might," "will," "should" or other words that convey uncertainty of future even ...
Ocugen(OCGN) - 2021 Q4 - Annual Report
2022-02-27 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________________________________ FORM 10-K ___________________________________________________________ (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36751 _______________________ ...
Ocugen(OCGN) - 2021 Q4 - Earnings Call Transcript
2022-02-25 15:52
Ocugen, Inc. (NASDAQ:OCGN) Q4 2021 Earnings Conference Call February 25, 2022 8:30 AM ET Company Participants Ken Inchausti - Head of Investor Relations & Communications Shankar Musunuri - Chairman, Chief Executive Officer & Co-Founder Sanjay Subramanian - Chief Financial Officer & Head of Corporate Development Conference Call Participants Zegbeh Jallah - ROTH Capital Partners Brian Cheng - Cantor Operator Good morning, and welcome to the Ocugen Conference Call. At this time, all participants are in a liste ...